Literature DB >> 25759532

Angiopoietin and vascular endothelial growth factor expression in colorectal disease models.

Wei-Xin Liu1, Shou-Zhi Gu1, Shen Zhang1, Yi Ren1, Li-Xuan Sang1, Cong Dai1.   

Abstract

AIM: To investigate angiopoietin (Ang) and vascular endothelial growth factor (VEGF) expression in rats with ulcerative colitis (UC) and colorectal cancer (CRC).
METHODS: Dysplasia and cancer were investigated in rats that received three cycles of 3.5% dextran sulfate sodium (DSS) in drinking water for 7 d followed by distilled water for 14 d after intraperitoneal pretreatment with 20 mg/kg 1,2-dimethylhydrazine (DMH) (CRC group). Colitis was investigated in rats that received three cycles of 3.5% DSS in drinking water for 7 d followed by distilled water for 14 d after intraperitoneal pretreatment with saline (UC group). Rats without DSS or DMH treatment served as controls. Expression of the tyrosine kinase with immunoglobulin-like and EGF-like domains (Tie)-2 and its ligands, Ang-1 and Ang-2, as well as VEGF were evaluated in the colorectum by Western blotting.
RESULTS: Compared with rats in the control group, rats in the CRC and UC groups developed the symptoms of acute colitis with diarrhea, rectal bleeding, wasting, and loss of body weight (P < 0.05). In addition, the mean length of colorectum of CRC and UC rats was significantly shorter than that of control rats (8.29 ± 0.21 and 8.31 ± 0.86, respectively, vs 12.34 ± 0.12 cm; P < 0.05). Furthermore, rats in the CRC group, but not in the UC or control groups, developed multiple tumors in the colorectal region. Western blot analysis revealed that rats in the CRC and UC groups had markedly increased protein levels of Ang-1, Ang-2, Tie-2, and VEGF in the colorectum compared to rats in the control group.
CONCLUSION: Increased expression of Ang-1, Ang-2, Tie-2, and VEGF in ulcerative colitis-derived colorectal cancer might lead to chronic colitis and pathologic angiogenesis in rats.

Entities:  

Keywords:  Angiopoietin-1; Angiopoietin-2; Colorectal cancer; Tie-2; Ulcerative colitis; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 25759532      PMCID: PMC4351214          DOI: 10.3748/wjg.v21.i9.2645

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 2.  Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts.

Authors:  Fernando Magro; Andreia Rodrigues; Ana Isabel Vieira; Francisco Portela; Isabelle Cremers; José Cotter; Luis Correia; Maria Antónia Duarte; Maria Lourdes Tavares; Paula Lago; Paula Ministro; Paula Peixe; Susana Lopes; Elizabeth Benito Garcia
Journal:  Inflamm Bowel Dis       Date:  2011-07-26       Impact factor: 5.325

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  A decision analysis of surveillance for colorectal cancer in ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

5.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

6.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

7.  Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance.

Authors:  B A Taylor; J H Pemberton; H A Carpenter; K E Levin; K W Schroeder; D R Welling; M P Spencer; A R Zinsmeister
Journal:  Dis Colon Rectum       Date:  1992-10       Impact factor: 4.585

Review 8.  Angiopoietins in tumours: the angiogenic switch.

Authors:  Catherine R Tait; Pamela F Jones
Journal:  J Pathol       Date:  2004-09       Impact factor: 7.996

9.  Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment.

Authors:  Jun-ichi Onose; Toshio Imai; Mai Hasumura; Makoto Ueda; Masao Hirose
Journal:  Cancer Lett       Date:  2003-08-20       Impact factor: 8.679

10.  Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation.

Authors:  Masayuki Hashimoto; Toranoshin Ayada; Ichiko Kinjyo; Kiyokazu Hiwatashi; Hideyuki Yoshida; Yasunori Okada; Takashi Kobayashi; Akihiko Yoshimura
Journal:  Cancer Sci       Date:  2009-04       Impact factor: 6.716

View more
  3 in total

1.  Potential suppressive effects of theophylline on human rectal cancer SW480 cells in vitro by inhibiting YKL-40 expression.

Authors:  Hong Peng; Qiang Su; Zhong-Chao Lin; Xiu-Hua Zhu; Ming-Sha Peng; Zhen-Bing Lv
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

2.  Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy.

Authors:  Adva Avisar; Miri Cohen; Benjamin Brenner; Tomer Bronshtein; Marcelle Machluf; Gil Bar-Sela; Anat Aharon
Journal:  Front Oncol       Date:  2020-08-26       Impact factor: 6.244

Review 3.  Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis.

Authors:  Pratiek N Matkar; Ramya Ariyagunarajah; Howard Leong-Poi; Krishna K Singh
Journal:  Biomolecules       Date:  2017-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.